The relevant disclosure with respect to Re-Schedule of Investor/Analysts'' Call is attached.
Awaiting price reaction for this filing.
Fortis Healthcare has rescheduled its post-results conference call with investors and analysts from 11:00 AM to 12:00 PM (noon) on May 21, 2025. The call will discuss the company's Q4FY25 and full year FY25 audited financial results. The meeting will be held virtually as a group conference call, with dial-in numbers provided for participants in India, the UK, US, Singapore, and Hong Kong. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the call. This update follows an earlier communication dated May 09, 2025.
This is a routine administrative change in call timing with no material business or financial implications. Shareholders and analysts should simply note the new 12:00 PM start time for the Q4FY25 results discussion.